Home/Filings/4/0001055726-22-000009
4//SEC Filing

Kim Jong Joseph 4

Accession 0001055726-22-000009

CIK 0001055726other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:38 PM ET

Size

17.2 KB

Accession

0001055726-22-000009

Insider Transaction Report

Form 4
Period: 2022-02-26
Kim Jong Joseph
DirectorChief Executive Officer10% Owner
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2022-02-2668,767137,533 total
    Common Stock (68,767 underlying)
  • Award

    Common Stock Option

    2022-02-26+627,700627,700 total
    Exercise: $3.22From: 2022-02-26Exp: 2032-02-26Common Stock (627,700 underlying)
  • Award

    Restricted Stock Unit

    2022-02-26+468,500468,500 total
    Common Stock (468,500 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-26+68,7671,297,425 total
  • Tax Payment

    Common Stock

    2022-02-26$3.22/sh20,045$64,5451,277,380 total
Holdings
  • Common Stock

    (indirect: By Son: JK2)
    33,533
  • Common Stock

    (indirect: By Son: JK1)
    33,775
  • Common Stock

    (indirect: By Daughter: EK)
    33,563
  • Common Stock

    (indirect: By Spouse)
    5,975
  • Common Stock

    (indirect: By Partnership)
    816,527
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
  • [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
  • [F3]The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1
  • filerCIK 0001464549

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:38 PM ET
Size
17.2 KB